Long-Acting Therapies Trials Tracker for Hepatitis C, Opioid Use and Overdose Prevention Therapy, and Malaria

As a partner in the LONGEVITY project, Treatment Action Group (TAG) released a trials tracker, an update of the 2024 Long-Acting Technologies Trials Tracker for Hepatitis C, Opioid Use and Overdose Prevention Therapy, and Malaria, providing a compilation of ongoing and recently completed clinical trials on long-acting therapies for HCV, opioid use and overdose prevention therapy, and malaria in the research and development pipeline.

The trials in the tracker are listed on the World Health Organization International Clinical Trials Registry Platform website, the Pan African Clinical Trials Registry, the European Union Clinical Trials Register, and the United States clinicaltrials.gov website.

The clinical trials were compiled between June 2 and September 11, 2025, and will be updated on an annual basis. Please send updates, corrections, or suggestions to Joelle Dountio Ofimboudem at jdountio@treatmentactiongroup.org.